BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22808086)

  • 1. Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.
    Lv K; Liu L; Wang L; Yu J; Liu X; Cheng Y; Dong M; Teng R; Wu L; Fu P; Deng W; Hu W; Teng L
    PLoS One; 2012; 7(7):e40008. PubMed ID: 22808086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A.X and Let-7 signaling.
    Wang L; Yuan C; Lv K; Xie S; Fu P; Liu X; Chen Y; Qin C; Deng W; Hu W
    PLoS One; 2013; 8(6):e67373. PubMed ID: 23840685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
    Promkan M; Liu G; Patmasiriwat P; Chakrabarty S
    Int J Cancer; 2009 Dec; 125(12):2820-8. PubMed ID: 19551867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lin28/let-7/Bcl-xL pathway: the underlying mechanism of drug resistance in Hep3B cells.
    Tian N; Han Z; Li Z; Zhou M; Fan C
    Oncol Rep; 2014 Sep; 32(3):1050-6. PubMed ID: 24970027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
    Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
    Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-208a stimulates the cocktail of SOX2 and β-catenin to inhibit the let-7 induction of self-renewal repression of breast cancer stem cells and formed miR208a/let-7 feedback loop via LIN28 and DICER1.
    Sun X; Jiang S; Liu J; Wang H; Zhang Y; Tang SC; Wang J; Du N; Xu C; Wang C; Qin S; Zhang J; Liu D; Zhang Y; Li X; Wang J; Dong J; Wang X; Xu S; Tao Z; Xu F; Zhou J; Wang T; Ren H
    Oncotarget; 2015 Oct; 6(32):32944-54. PubMed ID: 26460550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
    Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
    Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1.
    Wang R; Zhang T; Yang Z; Jiang C; Seng J
    J Cell Mol Med; 2018 Sep; 22(9):4068-4075. PubMed ID: 29971911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer.
    Tao WY; Liang XS; Liu Y; Wang CY; Pang D
    Int J Biol Sci; 2015; 11(1):48-58. PubMed ID: 25552929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer.
    Sultan M; Nearing JT; Brown JM; Huynh TT; Cruickshank BM; Lamoureaux E; Vidovic D; Dahn ML; Fernando W; Coyle KM; Giacomantonio CA; Langille MGI; Marcato P
    Mol Oncol; 2021 Aug; 15(8):2046-2064. PubMed ID: 33932086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.
    Zheng P; Dong L; Zhang B; Dai J; Zhang Y; Wang Y; Qin S
    Histochem Cell Biol; 2019 Oct; 152(4):281-291. PubMed ID: 31352515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.
    Hawthorne VS; Huang WC; Neal CL; Tseng LM; Hung MC; Yu D
    Mol Cancer Res; 2009 Apr; 7(4):592-600. PubMed ID: 19372587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
    Clark DW; Mitra A; Fillmore RA; Jiang WG; Samant RS; Fodstad O; Shevde LA
    Curr Cancer Drug Targets; 2008 Aug; 8(5):421-30. PubMed ID: 18690848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells.
    Liu Y; Li H; Feng J; Cui X; Huang W; Li Y; Su F; Liu Q; Zhu J; Lv X; Chen J; Huang D; Yu F
    PLoS One; 2013; 8(12):e83083. PubMed ID: 24349438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107.
    Teng R; Hu Y; Zhou J; Seifer B; Chen Y; Shen J; Wang L
    PLoS One; 2015; 10(12):e0143716. PubMed ID: 26636340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
    De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
    Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6.
    Zhu X; Li Y; Xie C; Yin X; Liu Y; Cao Y; Fang Y; Lin X; Xu Y; Xu W; Shen H; Wen J
    Int J Cancer; 2014 Sep; 135(6):1286-96. PubMed ID: 24510775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein.
    Li W; Fan J; Banerjee D; Bertino JR
    Mol Pharmacol; 1999 Jun; 55(6):1088-93. PubMed ID: 10347252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway.
    Wang L; Wang YX; Zhang DZ; Fang XJ; Sun PS; Xue HC
    Biomed Pharmacother; 2016 Mar; 78():301-307. PubMed ID: 26898455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.